Their Current Valuation Deserve Consideration: Ecolab Inc. (ECL), Rigel Pharmaceuticals, Inc. (RIGL) – Post Analyst

This post was originally published on this site

Their Current Valuation Deserve Consideration: Ecolab Inc. (ECL), Rigel Pharmaceuticals, Inc. (RIGL)  Post Analyst

Here’s what’s interesting to note about Ecolab Inc. (NYSE:ECL) right now: Its price-to-sales ratio of 2.86, is expensive relative to the Package Goods/Cosmetics …

This post was originally published on *this site*